SBC

+ Watchlist + Portfolio

SBC Medical Group Holdings Inc.

Regulated industry Consumer brandTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $5.07
52-Week Range: $2.78 – $5.30
Market Cap: $523.49M
P/E (TTM): 10.83
EPS (TTM): 0.47
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 1.98
PEG Ratio: 1.95
Return on Equity: 18.91%
Return on Assets: 11.32%
Gross Margin: 71.85%
Operating Margin: 38.55%
Profit Margin: 27.99%
Current Ratio: 3.31
Debt/Equity: 0.17
Total Debt: $48.23M
Free Cash Flow: $63.19M
Revenue Growth: 13.40%
Earnings Growth: 338.90%
Enterprise Value: $403.18M

SBC Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$174.16M	$193.54M	$205.42M	$173.61M
Cost of Revenue	$59.33M	$56.24M	$49.37M	$46.32M
Gross Profit	$114.83M	$137.30M	$156.05M	$127.28M
Selling, General & Admin	$93.48M	$66.23M	$70.69M	$59.80M
Operating Expenses	$93.48M	$66.23M	$70.69M	$59.80M
Operating Income	$21.35M	$71.07M	$85.36M	$67.49M
EBITDA	$29.64M	$85.87M	$77.28M	$84.91M
Pretax Income	$23.68M	$73.58M	$73.46M	$82.07M
Income Tax	$18.12M	$35.02M	$26.77M	$31.02M
Net Income	$6.32M	$39.37M	$46.61M	$50.99M
Diluted EPS	0.06	0.39	0.48	0.50
Diluted Shares	100.74M	100.74M	96.56M	103.00M

SBC Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$51.74M	$103.02M	$125.04M	$163.77M
Receivables	$43.65M	$53.13M	$48.19M	$53.10M
Inventory	$1.35M	$3.09M	$1.49M	$2.79M
Current Assets	$112.95M	$165.91M	$184.45M	$231.22M
Total Assets	$225.48M	$258.81M	$266.08M	$380.45M
Current Liabilities	$101.25M	$92.45M	$61.19M	$61.12M
Long-Term Debt	$5.53M	$13.01M	$6.51M	$33.73M
Total Debt	$16.13M	$22.87M	$12.21M	$51.64M
Total Liabilities	$117.63M	$115.00M	$71.06M	$117.14M
Retained Earnings	$103.48M	$142.85M	$189.46M	$240.45M
Shareholders' Equity	$105.25M	$142.16M	$195.11M	$248.28M
Working Capital	$11.70M	$73.45M	$123.26M	$170.10M

SBC Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$47.37K	$50.67M	$20.58M	$24.67M
Capital Expenditure	-$24.95M	-$11.21M	-$3.41M	-$2.70M
Free Cash Flow	-$24.99M	$39.46M	$17.17M	$21.96M
Depreciation & Amortisation	$5.93M	$12.25M	$3.80M	$2.68M
Stock-Based Compensation	—	$0.00	$13.02M	$0.00
Investing Cash Flow	-$32.65M	$1.79M	-$10.10M	-$20.97M
Financing Cash Flow	-$7.98M	$6.14M	$22.97M	$38.29M
Share Repurchases	—	—	$0.00	-$5.00M
Net Change in Cash	-$40.68M	$58.60M	$33.45M	$41.99M

SBC Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$47.33M	$43.36M	$43.35M	$39.57M	$43.06M	$49.19M
Cost of Revenue	$9.60M	$13.35M	$12.74M	$10.64M	$12.71M	$13.21M
Gross Profit	$37.73M	$30.01M	$30.61M	$28.93M	$30.35M	$35.98M
Selling, General & Admin	$12.82M	$14.39M	$13.95M	$18.63M	$12.23M	$16.19M
Operating Expenses	$13.53M	$15.46M	$14.73M	$16.08M	$12.63M	$17.02M
Operating Income	$24.20M	$14.55M	$15.88M	$12.85M	$17.72M	$18.96M
EBITDA	$32.09M	$14.23M	$19.30M	$19.30M	$19.64M	$20.82M
Pretax Income	$31.45M	$13.54M	$18.51M	$18.57M	$18.86M	$19.55M
Income Tax	$9.96M	$11.10M	$5.67M	$4.29M	$7.53M	$7.82M
Net Income	$21.50M	$2.46M	$12.82M	$14.20M	$11.31M	$10.69M
Diluted EPS	0.21	0.02	0.12	0.14	0.11	0.10
Diluted Shares	103.28M	103.51M	102.64M	102.58M	102.58M	102.58M

SBC Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$132.06M	$152.74M	$127.43M	$163.77M	$167.31M	$184.31M
Receivables	$67.02M	$73.20M	$83.83M	$53.10M	$58.36M	$64.91M
Inventory	$1.69M	$1.71M	$1.68M	$2.79M	$2.32M	$2.98M
Current Assets	$215.10M	$241.34M	$227.20M	$231.22M	$238.78M	$259.39M
Total Assets	$284.61M	$315.30M	$321.36M	$380.45M	$388.02M	$406.66M
Current Liabilities	$48.47M	$60.68M	$44.58M	$61.12M	$62.57M	$78.46M
Long-Term Debt	$6.81M	$7.03M	$18.08M	$33.73M	$31.45M	$25.94M
Total Debt	$14.10M	$15.53M	$28.15M	$51.64M	$51.90M	$48.23M
Total Liabilities	$58.28M	$70.65M	$73.30M	$117.14M	$117.64M	$126.74M
Retained Earnings	$210.97M	$213.42M	$226.25M	$240.45M	$251.76M	$262.45M
Shareholders' Equity	$226.45M	$244.59M	$247.99M	$248.28M	$255.34M	$263.84M
Working Capital	$166.63M	$180.66M	$182.62M	$170.10M	$176.21M	$180.93M

SBC Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$1.93M	-$8.34M	-$20.88M	$51.96M	$9.23M	$22.51M
Capital Expenditure	-$754.98K	-$510.80K	-$176.27K	-$1.26M	-$548.87K	-$464.95K
Free Cash Flow	$1.17M	-$8.85M	-$21.06M	$50.70M	$8.68M	$22.04M
Depreciation & Amortisation	$628.30K	$636.10K	$746.21K	$673.68K	$670.43K	$1.13M
Stock-Based Compensation	—	—	$0.00	$0.00	—	—
Investing Cash Flow	-$978.81K	$16.38M	-$12.16M	-$24.21M	-$528.02K	$565.23K
Financing Cash Flow	-$280.38K	$7.18M	$11.57M	$19.82M	-$1.84M	-$1.96M
Share Repurchases	—	—	-$2.58M	$0.00	—	—
Net Change in Cash	$669.43K	$15.22M	-$21.47M	$47.58M	$6.86M	$21.11M

Market Snapshot

About

SBC Medical Group Holdings Inc. is a medical aesthetics services provider operating primarily in Asia. The company offers non-invasive and minimally invasive aesthetic treatments through its network of clinics. SBC Medical Group focuses on skincare, body contouring, and other cosmetic procedures for health-conscious consumers.